Sera from patients with autoimmune diseases do not have circulating IgA antibodies against tissue transglutaminase

Sardy, M., Csikos, M., Geisen, C., Preisz, K., Kornsee, Z., Tomsits, E., Tox, U., Wieslander, J., Karpati, S., Paulsson, M. and Smyth, N. (2004) Sera from patients with autoimmune diseases do not have circulating IgA antibodies against tissue transglutaminase Journal of Investigative Dermatology, 123, p.A66. (doi:10.1111/j.1523-1747.2004.23244.x).


Full text not available from this repository.


After the identification of tissue transglutaminase (TGc) as the predominant endomysial autoantigen of coeliac disease and dermatitis herpetiformis, diagnostic ELISAs were produced. Sera from patients with a broad spectrum of autoimmune diseases or with nonautoimmune diseases involving enhanced apoptosis, cell lysis and/or putative secondary autoimmune processes showed false positive reactions in these assays, as detected by a number of investigators. Sera from 605 patients and controls were tested in a human TGc ELISA including 304 patients with autoimmune and 122 with other diseases. Anti-gliadin and anti-endomysium antibodies were also determined in 70 patients chosen at random. Overall 49% of all autoimmune sera were false positive in the human TGc ELISA. The difference between the median titers of the autoimmune and the control sera was significant in every case except for the pemphigus vulgaris sera (bullous pemphigoid, p¼0.012; pemphigus vulgaris, p¼0.152; SLE, p¼0.0005; antiphospholipid syndrome, p¼0.0002; for each of the other groups po0.0001). Significant differences were also found in serum titers between controls and patients with hepatitis C (po0.0001), psoriatic arthritis (p¼0.0065), and malignancies (p¼0.0005). Altogether 25% of the sera from patients with hepatitis C, psoriatic arthritis, and malignancies were positive in the human TGc ELISA. In contrast, testing 70 of the false positive patients for total serum IgA levels, AGA and EMA reactivity as well as immunoblots showed that no association of these conditions with gluten sensitive enteropathy can be confirmed. However, further purification of the TGc protein preparation used for coating and elevation of ionic strength in the buffers could eliminate false positive signals.
The currently used method for TGc ELISA allows nonspecific positivity of certain sera from patients having circulating IgA of high affinity against impurities. Thus it is evident that positivity of a TGc ELISA should not alone be taken as the basis for a diagnosis of coeliac disease or dermatitis herpetiformis.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1111/j.1523-1747.2004.23244.x
ISSNs: 0022-202X (print)
ePrint ID: 56406
Date :
Date Event
August 2004Published
Date Deposited: 11 Aug 2008
Last Modified: 16 Apr 2017 17:41
Further Information:Google Scholar

Actions (login required)

View Item View Item